146 related articles for article (PubMed ID: 10512494)
21. [Clinical efficacy of Pioglitazone (AD-4833)].
Kaneko T; Baba S
Nihon Rinsho; 1997 Nov; 55 Suppl():142-6. PubMed ID: 9434458
[No Abstract] [Full Text] [Related]
22. The glitazones: a new treatment for type 2 diabetes mellitus.
Bradley C
Intensive Crit Care Nurs; 2002 Jun; 18(3):189-91. PubMed ID: 12405274
[TBL] [Abstract][Full Text] [Related]
23. Lack of effect of pioglitazone on postprandial triglyceride levels in type 2 diabetes.
Shimono D; Kuwamura N; Nakamura Y; Koshiyama H
Diabetes Care; 2001 May; 24(5):971. PubMed ID: 11347775
[No Abstract] [Full Text] [Related]
24. The value equation for rosiglitazone and pioglitazone in older persons.
Zarowitz BJ
Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172
[No Abstract] [Full Text] [Related]
25. The oral insulin sensitizer, thiazolidinedione, increases plasma vascular endothelial growth factor in type 2 diabetic patients.
Baba T; Shimada K; Neugebauer S; Yamada D; Hashimoto S; Watanabe T
Diabetes Care; 2001 May; 24(5):953-4. PubMed ID: 11347762
[No Abstract] [Full Text] [Related]
26. Pioglitazone.
Lawrence JM; Reckless JP
Int J Clin Pract; 2000 Nov; 54(9):614-8. PubMed ID: 11220991
[TBL] [Abstract][Full Text] [Related]
27. Using thiazolidinediones: rosiglitazone and pioglitazone in clinical practice.
Peters AL
Am J Manag Care; 2001 Apr; 7(3 Suppl):S87-95; quiz S96-7. PubMed ID: 11310177
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and clinical efficacy of pioglitazone.
Hanefeld M
Int J Clin Pract Suppl; 2001 Sep; (121):19-25. PubMed ID: 11594240
[TBL] [Abstract][Full Text] [Related]
29. Rosiglitazone.
Goldstein BJ
Int J Clin Pract; 2000 Jun; 54(5):333-7. PubMed ID: 10954962
[TBL] [Abstract][Full Text] [Related]
30. Marked improvement of glycaemic control with pioglitazone in a Type 2 diabetic patient associated with Charcot-Marie-Tooth disease.
Ota T; Osawa K
Diabet Med; 2003 May; 20(5):420-1. PubMed ID: 12752495
[No Abstract] [Full Text] [Related]
31. [Thiazolidinediones in type 2 diabetes].
Baum U
Med Monatsschr Pharm; 2000 Jul; 23(7):210-3. PubMed ID: 10941251
[No Abstract] [Full Text] [Related]
32. Pioglitazone-associated fulminant hepatic failure.
Chase MP; Yarze JC
Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
[No Abstract] [Full Text] [Related]
33. New drug overview. Pioglitazone hydrochloride.
Am J Health Syst Pharm; 2000 Jan; 57(2):124-5. PubMed ID: 10688239
[No Abstract] [Full Text] [Related]
34. Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients.
Diabetes Technol Ther; 2000; 2(2):292. PubMed ID: 11469275
[No Abstract] [Full Text] [Related]
35. Rosiglitazone and type 2 diabetes mellitus.
Bragg T
Lancet; 2001 May; 357(9266):1451. PubMed ID: 11360960
[No Abstract] [Full Text] [Related]
36. [The efficacy and safety of pioglitazone hydrochloride in combination with sulphonylureas and metfomin in the treatment of type 2 diabetes mellitus a 12-week randomized multi-centres placebo-controlled parallel study].
Pan C; Gao Y; Gao X; Li G; Luo B; Shi H; Tian H; Jia P; Lin H; Xing X; Zhao Y; Zhou L
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):388-92. PubMed ID: 12137601
[TBL] [Abstract][Full Text] [Related]
37. NICE issues guidance on diabetes treatments.
Iles A
BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958096
[No Abstract] [Full Text] [Related]
38. [Thiazolidinediones].
Scheen AJ; Paquot N; Letiexhe MR; Lefèbvre PJ
Journ Annu Diabetol Hotel Dieu; 1999; ():213-29. PubMed ID: 10732419
[No Abstract] [Full Text] [Related]
39. Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.
Rosenstock J; Einhorn D; Hershon K; Glazer NB; Yu S;
Int J Clin Pract; 2002 May; 56(4):251-7. PubMed ID: 12074206
[TBL] [Abstract][Full Text] [Related]
40. Thiazolidinediones in diabetes: current status and future outlook.
Camp HS
Curr Opin Investig Drugs; 2003 Apr; 4(4):406-11. PubMed ID: 12808879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
